TY - JOUR
T1 - Circadian Rhythms and Astrocytes
T2 - The Good, the Bad, and the Ugly
AU - Hastings, Michael H.
AU - Brancaccio, Marco
AU - Gonzalez-Aponte, Maria F.
AU - Herzog, Erik D.
N1 - Publisher Copyright:
Copyright © 2023 by Medical Research Council Laboratory of Molecular Biology.
PY - 2023/7/10
Y1 - 2023/7/10
N2 - This review explores the interface between circadian timekeeping and the regulation of brain function by astrocytes. Although astrocytes regulate neuronal activity across many time domains, their cell-autonomous circadian clocks exert a particular role in controlling longer-term oscillations of brain function: the maintenance of sleep states and the circadian ordering of sleep and wakefulness. This is most evident in the central circadian pacemaker, the suprachiasmatic nucleus, where the molecular clock of astrocytes suffices to drive daily cycles of neuronal activity and behavior. In Alzheimer’s disease, sleep impairments accompany cognitive decline. In mouse models of the disease, circadian disturbances accelerate astroglial activation and other brain pathologies, suggesting that daily functions in astrocytes protect neuronal homeostasis. In brain cancer, treatment in the morning has been associated with prolonged survival, and gliomas have daily rhythms in gene expression and drug sensitivity. Thus, circadian time is fast becoming critical to elucidating reciprocal astrocytic-neuronal interactions in health and disease.
AB - This review explores the interface between circadian timekeeping and the regulation of brain function by astrocytes. Although astrocytes regulate neuronal activity across many time domains, their cell-autonomous circadian clocks exert a particular role in controlling longer-term oscillations of brain function: the maintenance of sleep states and the circadian ordering of sleep and wakefulness. This is most evident in the central circadian pacemaker, the suprachiasmatic nucleus, where the molecular clock of astrocytes suffices to drive daily cycles of neuronal activity and behavior. In Alzheimer’s disease, sleep impairments accompany cognitive decline. In mouse models of the disease, circadian disturbances accelerate astroglial activation and other brain pathologies, suggesting that daily functions in astrocytes protect neuronal homeostasis. In brain cancer, treatment in the morning has been associated with prolonged survival, and gliomas have daily rhythms in gene expression and drug sensitivity. Thus, circadian time is fast becoming critical to elucidating reciprocal astrocytic-neuronal interactions in health and disease.
KW - Alzheimer’s disease
KW - calcium signaling
KW - circadian clock
KW - glioma
KW - gliotransmitter
KW - sleep
UR - http://www.scopus.com/inward/record.url?scp=85153408568&partnerID=8YFLogxK
U2 - 10.1146/annurev-neuro-100322-112249
DO - 10.1146/annurev-neuro-100322-112249
M3 - Review article
C2 - 36854316
AN - SCOPUS:85153408568
SN - 0147-006X
VL - 46
SP - 123
EP - 143
JO - Annual Review of Neuroscience
JF - Annual Review of Neuroscience
ER -